Source: BUSINESS WIRE

Press Release: Thrasos : Thrasos Completes Enrollment of Phase 2 THR-184 Clinical Study for Acute Kidney Injury

MONTREAL--(BUSINESS WIRE)--"This large, important study targets patients with few treatment options. We are eager to see if THR-184 will prevent the development of acute kidney injury for patients undergoing cardiac surgery."

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more